81 related articles for article (PubMed ID: 24801571)
1. Structure of the human P2Y₁₂ receptor in complex with an antithrombotic drug.
Du B; Liu M
Sci China Life Sci; 2014 Jun; 57(6):645-6. PubMed ID: 24801571
[No Abstract] [Full Text] [Related]
2. Structure of the human P2Y12 receptor in complex with an antithrombotic drug.
Zhang K; Zhang J; Gao ZG; Zhang D; Zhu L; Han GW; Moss SM; Paoletta S; Kiselev E; Lu W; Fenalti G; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
Nature; 2014 May; 509(7498):115-8. PubMed ID: 24670650
[TBL] [Abstract][Full Text] [Related]
3. Agonist-bound structure of the human P2Y12 receptor.
Zhang J; Zhang K; Gao ZG; Paoletta S; Zhang D; Han GW; Li T; Ma L; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
Nature; 2014 May; 509(7498):119-22. PubMed ID: 24784220
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of action for reversible P2Y12 antagonists.
Liu H; Ge H; Peng Y; Xiao P; Xu J
Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362
[TBL] [Abstract][Full Text] [Related]
5. Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y
Zhou S; Fang D; Tan S; Lin W; Wu W; Zheng K
J Biomol Struct Dyn; 2017 Oct; 35(13):2938-2965. PubMed ID: 27634290
[TBL] [Abstract][Full Text] [Related]
6. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information.
Paoletta S; Sabbadin D; von Kügelgen I; Hinz S; Katritch V; Hoffmann K; Abdelrahman A; Straßburger J; Baqi Y; Zhao Q; Stevens RC; Moro S; Müller CE; Jacobson KA
J Comput Aided Mol Des; 2015 Aug; 29(8):737-56. PubMed ID: 26194851
[TBL] [Abstract][Full Text] [Related]
7. Optimization of P2Y
Kong D; Xue T; Guo B; Cheng J; Liu S; Wei J; Lu Z; Liu H; Gong G; Lan T; Hu W; Yang Y
J Med Chem; 2019 Mar; 62(6):3088-3106. PubMed ID: 30843696
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y
Liu X; Gao ZG; Wu Y; Stevens RC; Jacobson KA; Zhao S
Sci Rep; 2018 May; 8(1):8084. PubMed ID: 29795391
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic P2Y
Baqi Y; Müller CE
Drug Discov Today; 2019 Jan; 24(1):325-333. PubMed ID: 30291899
[TBL] [Abstract][Full Text] [Related]
10. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
[TBL] [Abstract][Full Text] [Related]
11. Prediction of P2Y12 antagonists using a novel genetic algorithm-support vector machine coupled approach.
Hao M; Li Y; Wang Y; Zhang S
Anal Chim Acta; 2011 Mar; 690(1):53-63. PubMed ID: 21414436
[TBL] [Abstract][Full Text] [Related]
12. Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility.
Wang TC; Qiao JX; Clark CG; Jua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Everlof G; Schumacher WA; Wong PC; Seiffert DA; Stewart AB; Bostwick JS; Crain EJ; Watson CA; Rehfuss R; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2013 Jun; 23(11):3239-43. PubMed ID: 23602442
[TBL] [Abstract][Full Text] [Related]
13. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
[TBL] [Abstract][Full Text] [Related]
14. Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations.
Giordanetto F; Bach P; Zetterberg F; Antonsson T; Bylund R; Johansson J; Sellén M; Brown D; Hideståhl L; Berntsson P; Hovdal D; Zachrisson H; Björkman JA; van Giezen JJ
Bioorg Med Chem Lett; 2014 Jul; 24(13):2963-8. PubMed ID: 24835983
[TBL] [Abstract][Full Text] [Related]
15. Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283.
Bach P; Antonsson T; Bylund R; Björkman JA; Österlund K; Giordanetto F; van Giezen JJ; Andersen SM; Zachrisson H; Zetterberg F
J Med Chem; 2013 Sep; 56(17):7015-24. PubMed ID: 23899349
[TBL] [Abstract][Full Text] [Related]
16. Docking-based virtual screening of potential human P2Y12 receptor antagonists.
Chen H; Dong X; Zhou M; Shi H; Luo X
Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):400-8. PubMed ID: 21474491
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents.
Zhang H; Liu J; Zhang L; Kong L; Yao H; Sun H
Bioorg Med Chem Lett; 2012 Jun; 22(11):3598-602. PubMed ID: 22546677
[TBL] [Abstract][Full Text] [Related]
18. P2Y1 receptor antagonists as novel antithrombotic agents.
Pfefferkorn JA; Choi C; Winters T; Kennedy R; Chi L; Perrin LA; Lu G; Ping YW; McClanahan T; Schroeder R; Leininger MT; Geyer A; Schefzick S; Atherton J
Bioorg Med Chem Lett; 2008 Jun; 18(11):3338-43. PubMed ID: 18445527
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.
Chao H; Turdi H; Herpin TF; Roberge JY; Liu Y; Schnur DM; Poss MA; Rehfuss R; Hua J; Wu Q; Price LA; Abell LM; Schumacher WA; Bostwick JS; Steinbacher TE; Stewart AB; Ogletree ML; Huang CS; Chang M; Cacace AM; Arcuri MJ; Celani D; Wexler RR; Lawrence RM
J Med Chem; 2013 Feb; 56(4):1704-14. PubMed ID: 23368907
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists.
Tu W; Fan J; Zhang H; Xu G; Liu Z; Qu J; Yang F; Zhang L; Luan T; Yuan J; Gong A; Feng J; Sun P; Dong Q
Bioorg Med Chem Lett; 2014 Jan; 24(1):141-6. PubMed ID: 24332627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
